Page last updated: 2024-11-13

orm-12741

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ORM-12741: an alpha-2C adrenoceptor antagonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID71301276
CHEMBL ID4297312
SCHEMBL ID22635928
MeSH IDM000594916

Synonyms (15)

Synonym
S900006170
orm 12741
orm12741
orm-12741
unii-c5d3yg7zr8
orm-10921
(1s,12bs)-1,3,4,6,7,12b-hexahydro-1-(methoxymethyl)-1-methyl-2h-benzofuro(2,3-a)quinolizine
c5d3yg7zr8 ,
610782-82-6
DB12057
Q27276003
CHEMBL4297312
SCHEMBL22635928
(1s,12bs)-1,3,4,6,7,12b-hexahydro-1-(methoxymethyl)-1-methyl-2h-benzofuro[2,3-a]quinolizine
AKOS040749095

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The role of the α2C-AR in modulating two key depression-related behaviours in the Flinders Sensitive Line (FSL) rat was studied using a dose-response analysis following subcutaneous administration with the selective α2C-AR antagonist ORM-10921 (0."( The α2C-adrenoceptor antagonist, ORM-10921, exerts antidepressant-like effects in the Flinders Sensitive Line rat.
Harvey, BH; Sallinen, J; Shahid, M; Uys, MM, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.28 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (20.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]